SEARCH RESULT

Total Matching Records found : 1922

Bill Gates meets Montek Singh Ahluwalia to discuss healthcare issues -Yogima Seth Sharma

-The Economic Times NEW DELHI: US business leader and philanthropist Bill Gates met Planning Commission deputy chairman Montek Singh Ahluwalia on Wednesday to discuss healthcare issues, including India's low healthcare expenditure. "There were discussions on healthcare and vaccination. He appreciated the progress in immunization programme in India," a senior planning commission official told ET. India's 12th Five Year plan has projected to increase healthcare spending to 2.5% of GDP compared to little...

More »

Costly Ethanol import likely to make petrol pricier by 4 rupees-Rajeev Jayaswal

-The Economic Times NEW DELHI: Petrol could become costlier by about 4 a litre if the government compels oil firms to sell 5% ethanol-blended petrol across the country by next month as these companies would be forced to import huge quantities of the biofuel at exorbitant rates. But, the Cabinet, which will meet soon to discuss the issue, may relax compulsory doping as it would want petrol prices to rise sharply, months...

More »

Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times

-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...

More »

USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman

-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...

More »

From Bofors to 2G, the same fate-Arun Kumar

-The Hindu   The parliamentary committees on the howitzer scam and the stock market scandal protected the powerful and failed to fix accountability. The same is true in the spectrum case The current political situation brings back memories of 1989. The Prime Minister then was under a cloud in the Bofors scam. Many of his close associates like Lalit Suri and Ajitabh Bachchan were accused of wrong-doing. Today, Prime Minister Manmohan Singh and...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close